Nuvo Pharmaceuticals Inc. is a Canada-based healthcare company. The Company is engaged in offering diversified portfolio of commercial products. It operates through three segments: Commercial Business, Production and Service Business and Licensing and Royalty Business. The Commercial Business segment is comprised of products commercialized by the Company in Canada. It includes products, such as Blexten, Cambia, Suvexx and NeoVisc, as well as mature products. The Production and Service Business segment includes sale of products manufactured by the Company from its manufacturing facility in Varennes, Quebec or contracted by Miravo Ireland from its international headquarters in Dublin, Ireland, as well as service for testing, development and related quality assurance and quality control services provided by the Company. The Licensing and Royalty Business segment includes the revenue by the licensing of intellectual property and ongoing royalties from licensing agreements with partners.